HYPNOsis in the Management of Atopic Dermatitis in Children and Teenagers

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE LA RÉUNION · Nov 3, 2022

Keywords

ClinConnect Summary

The clinical trial titled "HYPNOsis in the Management of Atopic Dermatitis in Children and Teenagers" is exploring the use of medical hypnosis as a treatment for atopic dermatitis (AD), a common skin condition in children that causes itching and skin irritation. Researchers believe that hypnosis may help reduce itching and skin pain, improve sleep and mood, and even lead to healing in some cases. This trial aims to first test the feasibility of a hypnosis program, which could lead to a larger study in the future.

To participate, children aged 8 to 17 who speak French and have been diagnosed with moderate to severe atopic dermatitis may be eligible. Participants need to have a doctor’s referral and must be willing to take part in hypnosis sessions. Those who refuse hypnosis, cannot listen to audio files, or have certain psychiatric issues will not be included. If your child participates, they can expect to engage in soothing hypnosis sessions that aim to help manage their skin condition and improve their overall well-being.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Children aged 8 to 17 years
• • Understanding french
• • With moderate to severe AD clinically diagnosed by a physician (SCORing Atopic Dermatitis (SCORAD) ≥ 25)
• • Referred by their referring physician in the Reunionese therapeutic education program for AD provided within the atopy school of the Reunion University Hospital. - Oral consent of the child and of one of the legal representatives collected.
• Exclusion Criteria:
• • Children refusing to participate in the hypnosis session
• • Not having the possibility to listen to an audio file,
• • Already practicing self-hypnosis for their AD before inclusion,
• • Having a contraindication to hypnosis (psychiatric disorders, psychosis)
• • Treated by a systemic treatment for their AD.